Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fute (Flupentixol) as adjunctive therapy in MARTAs-treated schizophrenia
NCT04898270Phase 4Completed
- Sponsor
- Taichung Veterans General Hospital
- Start
- Dec 2019
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in schizophrenia, sponsored by Taichung Veterans General Hospital. Primary endpoints: Clinical Global Impression-Severity at 12 weeks and Positive and Negative Syndrome Scale at 12 weeks. Started Dec 2019; status: completed.
02
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT04898270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04898270.